ArticleBritish journal of cancer2025

Integrative proteo-genomic profiling uncovers key biomarkers of lapatinib resistance in HER2-positive breast cancer.

J Steggall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.